Medicare Enrolled
Dr. Jorge Rios-Perez, M.D.
Medical Oncology · Columbus, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rios-Perez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rios-Perez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rios-Perez
Dr. Jorge Rios-Perez is a medical oncology specialist in Columbus, OH, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rios-Perez performed 15,465 Medicare services across 1,114 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rios-Perez received a total of $2,232 from 51 pharmaceutical and/or device companies across 121 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rios-Perez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 16% volume in OH
$2,232 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,465
Medicare services
Top 16% in OH for medical oncology
1,114
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~910 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
6,760 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 3,770 | $1 | $6 |
| Iron infusion (Monoferric) | 1,200 | $15 | $74 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
690 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
575 | $7 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 400 | $1 | $41 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
277 | $2 | $39 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
271 | $93 | $390 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
228 | $60 | $277 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
209 | $93 | $421 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
180 | $8 | $9 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
105 | $10 | $67 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
99 | $21 | $103 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
81 | $71 | $210 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
68 | $53 | $368 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $60 | $214 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
46 | $47 | $205 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
44 | $155 | $733 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
44 | $21 | $164 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
44 | $116 | $509 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
43 | $8 | $26 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
42 | $11 | $66 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
37 | $1 | $4 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
34 | $45 | $208 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
31 | $5 | $16 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
31 | $1 | $6 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
22 | $26 | $121 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $97 | $406 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
19 | $38 | $117 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
18 | $3 | $12 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
16 | $771 | $4,447 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $118 | $595 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.3% high complexity
79.6% medium
10.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,232
Total received (2018-2024)
Avg $319/year across 7 years
Bottom 49% in OH for medical oncology
51
Companies
121
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,153 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$79 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$344
2023
$412
2022
$682
2021
$298
2020
$292
2019
$87
2018
$116
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SpringWorks Therapeutics, Inc.
$56
Eisai Inc.
$42
PFIZER INC.
$34
E.R. Squibb & Sons, L.L.C.
$32
Aveo Pharmaceuticals, Inc.
$25
Merck Sharp & Dohme LLC
$23
Daiichi Sankyo Inc.
$22
Novartis Pharmaceuticals Corporation
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
AstraZeneca Pharmaceuticals LP
$19
Kite Pharma, Inc.
$18
Iovance Biotherapeutics, Inc.
$17
Genmab U.S., Inc.
$16
Top 3 companies account for 38.2% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$252
Sirtex Medical Inc
$142
Novartis Pharmaceuticals Corporation
$126
Celgene Corporation
$115
E.R. Squibb & Sons, L.L.C.
$100
AstraZeneca Pharmaceuticals LP
$95
PFIZER INC.
$88
Genentech USA, Inc.
$61
Amgen Inc.
$60
BeiGene USA, Inc.
$60
Daiichi Sankyo Inc.
$59
EISAI INC.
$57
Janssen Biotech, Inc.
$57
SpringWorks Therapeutics, Inc.
$56
Takeda Pharmaceuticals U.S.A., Inc.
$54
GlaxoSmithKline, LLC.
$51
Seagen Inc.
$47
Kite Pharma, Inc.
$46
Taiho Oncology, Inc.
$40
GENZYME CORPORATION
$40
Foundation Medicine, Inc.
$40
Gilead Sciences, Inc.
$37
Merck Sharp & Dohme LLC
$36
Coherus Biosciences Inc.
$31
AMAG Pharmaceuticals, Inc.
$30
JAZZ PHARMACEUTICALS INC.
$30
Pharmacyclics LLC, an AbbVie Company
$27
Aveo Pharmaceuticals, Inc.
$25
Alexion Pharmaceuticals, Inc.
$23
Acrotech Biopharma LLC
$22
AVEO Pharmaceuticals, Inc.
$21
Incyte Corporation
$19
Deciphera Pharmaceuticals Inc.
$19
CTI BioPharma Corp.
$19
Sobi, Inc
$19
Regeneron Healthcare Solutions, Inc.
$18
Pharmacyclics LLC, An AbbVie Company
$18
Iovance Biotherapeutics, Inc.
$17
Genmab U.S., Inc.
$16
Rigel Pharmaceuticals, Inc.
$16
Agios Pharmaceuticals, Inc.
$16
Exelixis Inc.
$16
ImmunoGen, Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
Merck Sharp & Dohme Corporation
$13
ADC Therapeutics America, Inc.
$13
Dova Pharmaceuticals
$13
Heron Therapeutics, Inc.
$12
EMD Serono, Inc.
$12
Astellas Pharma US Inc
$12
Clovis Oncology, Inc.
$9
Top 3 companies account for 23.3% of all-time payments
Associated products mentioned in payments ›
Abraxane · Alecensa · Amtagvi · BRUKINSA · Bavencio · Cabometyx · DARZALEX · DOPTELET · Doptelet · ENHERTU · EPKINLY · ERLEADA · Elahere · Enhertu · Epkinly · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · Folotyn · IBRANCE · IMBRUVICA · IMFINZI · INQOVI · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · Lenvima · Lonsurf · NINLARO · OGSIVEO · OPDIVO · PADCEV · PLUVICTO · PROMACTA · Perjeta · Pomalyst · QINLOCK · Rubraca · SANDOSTATIN LAR · SHINGRIX · SIR-Spheres Microspheres · SUSTOL · TAGRISSO · TIBSOVO · TUKYSA · Tavalisse · ULTOMIRIS · Udenyca · Vonjo · XGEVA · XTANDI · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
70
Per 100K population
5.3
County median income
$73,795
Nearest hospital
RIVER VISTA HEALTH AND WELLNESS LLC
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rios-Perez is a mixed practice specialist, with above-average Medicare volume (top 16% in OH), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rios-Perez experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Rios-Perez performed 6,760 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rios-Perez receive payments from pharmaceutical companies?
Yes. Dr. Rios-Perez received a total of $2,232 from 51 companies across 121 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rios-Perez's costs compare to other medical oncologists in Columbus?
Dr. Rios-Perez's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rios-Perez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Columbus
Browse medical oncologists in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in OH
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in OH
Which OH medical oncologists receive the most from drug and device companies.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
Sirtex Medical Inc Payments to Doctors
See all physicians who received payments from Sirtex Medical Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology